print logo
RSS FEED

AMERICAN.COM

The Journal of the American Enterprise Institute

Email the editor

Is Competition Coming?


Geoffrey Allan, CEO of biotechnology firm Insmed, discusses the benefits of generic competition for biologic drugs.

(Required)
(Required)
(Required)